他汀类药物-低胆固醇-癌症难题 - Suppr

Suppr

超能文献

The statin-low cholesterol-cancer conundrum.

作者信息

Ravnskov U, McCully K S, Rosch P J

出版信息

QJM. 2012 Apr;105(4):383-8. doi: 10.1093/qjmed/hcr243. Epub 2011 Dec 8.

DOI:10.1093/qjmed/hcr243

PMID:22156736

Abstract

摘要

相似文献

The statin-low cholesterol-cancer conundrum.

QJM. 2012 Apr;105(4):383-8. doi: 10.1093/qjmed/hcr243. Epub 2011 Dec 8.

Statin treatment does not cause cancer.

J Am Coll Cardiol. 2008 Sep 30;52(14):1148-9. doi: 10.1016/j.jacc.2008.06.036.

Low LDL-C levels and cancer reassuring but still not definitive.

J Am Coll Cardiol. 2008 Sep 30;52(14):1150-1. doi: 10.1016/j.jacc.2008.08.001.

Do statins decrease cardiovascular disease at the expense of increasing cancer?

Int J Cardiol. 2009 Apr 3;133(2):254-5. doi: 10.1016/j.ijcard.2007.11.020. Epub 2007 Dec 31.

Statins, low-density lipoprotein cholesterol, and risk of cancer.

J Am Coll Cardiol. 2008 Sep 30;52(14):1141-7. doi: 10.1016/j.jacc.2008.06.037.

Risk associated with statin treatment.

J Am Coll Cardiol. 2008 Jan 1;51(1):91; author reply 92. doi: 10.1016/j.jacc.2007.08.056.

[Cancer patients should not be treated with statins].

Ugeskr Laeger. 2013 Jan 7;175(1-2):76.

Should we lower cholesterol as much as possible?

BMJ. 2006 Jun 3;332(7553):1330-2. doi: 10.1136/bmj.332.7553.1330.

Cholesterol-lowering and cancer in the prevention of cardiovascular disease.

QJM. 2010 Mar;103(3):202. doi: 10.1093/qjmed/hcp186. Epub 2010 Jan 18.

The influence of statin medications on prostate-specific antigen levels.

J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362. Epub 2008 Oct 28.

引用本文的文献

Low apolipoprotein B and LDL-cholesterol are associated with the risk of cardiovascular and all-cause mortality: a prospective cohort.

Ann Med. 2025 Dec;57(1):2529565. doi: 10.1080/07853890.2025.2529565. Epub 2025 Jul 11.

Elevated remnant cholesterol and triglycerides are predictors of increased total mortality in a primary health care population of 327,347 patients.

Lipids Health Dis. 2025 May 24;24(1):189. doi: 10.1186/s12944-025-02607-5.

Metabolic syndrome and bladder cancer risk: a comprehensive evidence synthesis combining bibliometric and meta-analysis approaches.

BMC Urol. 2025 May 21;25(1):132. doi: 10.1186/s12894-025-01812-9.

Efficacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis.

Front Oncol. 2024 Sep 9;14:1428937. doi: 10.3389/fonc.2024.1428937. eCollection 2024.

Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms.

Front Endocrinol (Lausanne). 2024 Sep 3;15:1396022. doi: 10.3389/fendo.2024.1396022. eCollection 2024.

Investigating the Relationship between Body Mass Index, Cholesterol, and Cancer in United States Adults: A Cross-Sectional Study.

Diseases. 2024 Jun 4;12(6):120. doi: 10.3390/diseases12060120.

Role of non-canonical post-translational modifications in gastrointestinal tumors.

Cancer Cell Int. 2023 Sep 30;23(1):225. doi: 10.1186/s12935-023-03062-x.

Targeting Conserved Pathways in 3D Spheroid Formation of Diverse Cell Types for Translational Application: Enhanced Functional and Antioxidant Capacity.

Cells. 2023 Aug 11;12(16):2050. doi: 10.3390/cells12162050.

Optimal LDL cholesterol levels in young and old patients with type 2 diabetes for secondary prevention of cardiovascular diseases are different.

Endocr Connect. 2023 Sep 27;12(11). doi: 10.1530/EC-23-0142. Print 2023 Nov 1.

Dyslipidemia paradox: Analysis from the veterans exercise testing study.

PLoS One. 2023 Jul 19;18(7):e0287923. doi: 10.1371/journal.pone.0287923. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The statin-low cholesterol-cancer conundrum.

作者信息

Ravnskov U, McCully K S, Rosch P J

出版信息

QJM. 2012 Apr;105(4):383-8. doi: 10.1093/qjmed/hcr243. Epub 2011 Dec 8.

DOI:10.1093/qjmed/hcr243

PMID:22156736

Abstract

摘要

相似文献

The statin-low cholesterol-cancer conundrum.

QJM. 2012 Apr;105(4):383-8. doi: 10.1093/qjmed/hcr243. Epub 2011 Dec 8.

Statin treatment does not cause cancer.

J Am Coll Cardiol. 2008 Sep 30;52(14):1148-9. doi: 10.1016/j.jacc.2008.06.036.

Low LDL-C levels and cancer reassuring but still not definitive.

J Am Coll Cardiol. 2008 Sep 30;52(14):1150-1. doi: 10.1016/j.jacc.2008.08.001.

Do statins decrease cardiovascular disease at the expense of increasing cancer?

Int J Cardiol. 2009 Apr 3;133(2):254-5. doi: 10.1016/j.ijcard.2007.11.020. Epub 2007 Dec 31.

Statins, low-density lipoprotein cholesterol, and risk of cancer.

J Am Coll Cardiol. 2008 Sep 30;52(14):1141-7. doi: 10.1016/j.jacc.2008.06.037.

Risk associated with statin treatment.

J Am Coll Cardiol. 2008 Jan 1;51(1):91; author reply 92. doi: 10.1016/j.jacc.2007.08.056.

[Cancer patients should not be treated with statins].

Ugeskr Laeger. 2013 Jan 7;175(1-2):76.

Should we lower cholesterol as much as possible?

BMJ. 2006 Jun 3;332(7553):1330-2. doi: 10.1136/bmj.332.7553.1330.

Cholesterol-lowering and cancer in the prevention of cardiovascular disease.

QJM. 2010 Mar;103(3):202. doi: 10.1093/qjmed/hcp186. Epub 2010 Jan 18.

The influence of statin medications on prostate-specific antigen levels.

J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362. Epub 2008 Oct 28.

引用本文的文献

Low apolipoprotein B and LDL-cholesterol are associated with the risk of cardiovascular and all-cause mortality: a prospective cohort.

Ann Med. 2025 Dec;57(1):2529565. doi: 10.1080/07853890.2025.2529565. Epub 2025 Jul 11.

Elevated remnant cholesterol and triglycerides are predictors of increased total mortality in a primary health care population of 327,347 patients.

Lipids Health Dis. 2025 May 24;24(1):189. doi: 10.1186/s12944-025-02607-5.

Metabolic syndrome and bladder cancer risk: a comprehensive evidence synthesis combining bibliometric and meta-analysis approaches.

BMC Urol. 2025 May 21;25(1):132. doi: 10.1186/s12894-025-01812-9.

Efficacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis.

Front Oncol. 2024 Sep 9;14:1428937. doi: 10.3389/fonc.2024.1428937. eCollection 2024.

Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms.

Front Endocrinol (Lausanne). 2024 Sep 3;15:1396022. doi: 10.3389/fendo.2024.1396022. eCollection 2024.

Investigating the Relationship between Body Mass Index, Cholesterol, and Cancer in United States Adults: A Cross-Sectional Study.

Diseases. 2024 Jun 4;12(6):120. doi: 10.3390/diseases12060120.

Role of non-canonical post-translational modifications in gastrointestinal tumors.

Cancer Cell Int. 2023 Sep 30;23(1):225. doi: 10.1186/s12935-023-03062-x.

Targeting Conserved Pathways in 3D Spheroid Formation of Diverse Cell Types for Translational Application: Enhanced Functional and Antioxidant Capacity.

Cells. 2023 Aug 11;12(16):2050. doi: 10.3390/cells12162050.

Optimal LDL cholesterol levels in young and old patients with type 2 diabetes for secondary prevention of cardiovascular diseases are different.

Endocr Connect. 2023 Sep 27;12(11). doi: 10.1530/EC-23-0142. Print 2023 Nov 1.

Dyslipidemia paradox: Analysis from the veterans exercise testing study.

PLoS One. 2023 Jul 19;18(7):e0287923. doi: 10.1371/journal.pone.0287923. eCollection 2023.